Summary A group of 28 uraemic patients on dialysis treatment were given daily supplements of histidine by mouth. Plasma amino-acid concentration, plasma iron, serum transferrin, packed cell volume, and reticulocyte count were all measured before and after two months of histidine supplementation. The treatment raised the plasma histidine concentration and at the same time there was a rise in transferrin and iron levels and packed cell volume. Reticulocyte counts fell after two months of histidine supplementation.
Introduction
The role of histidine in cases of uraemia was investigated after the finding of low plasma levels of this amino-acid in patients with uraemia and the small extent of incorporation of 15N into histidine in isotopic experiments (Giordano et al., , 1968a . In earlier work it was shown that adding a small dose of histidine to the diet could result in im-proved nitrogen balance but generally resulted in increased globin synthesis (Giordano et al., b, 1970 (Giordano et al., , 1972 . In fact, it was shown in vitro that reticulocytes of uraemic patients incorporated radioactive leucine at a faster rate when they came from patients who had been given histidine supplements.
It seemed then that histidine, though considered a non-essential amino-acid for man, was acting in uraemia as a limiting aminoacid; and we suggested that it may be indispensable in patients with uraemia.
Anaemia is one of the more important clinical symptoms of uraemia, but relatively little has been achieved therapeutically either in dialysed or in non-dialysed patients. We have studied further the effect of histidine on the anaemia of uraemic patients, and our results indicate that histidine supplementation represents a new and promising approach to the problem.
Methods
A group of dialysed patients (one child and 27 adults) ranging from 8 to 57 years of age were studied at our centre. All were allowed a free diet after the usual instructions on electrolyte and water restrictions. The pa;ients had been dialysed with coil kidneys for periods of from six months to six years. Clinical diagnosis and weekly hours of dialysis are given in table I. The study was first designed to include 36 patients but those who had ruptures of coils during dialysis were later excluded. The 28 patients who completed this study had no blood transfusions either before or during the study period. Supplements of iron and folic acid consisted of polyvitamin capsules containing 10 mg iron as sulphate, 1 mg copper as oxide, and 1 mg folic acid. Supplementation had been started at the beginning of dialysis treatment. Each patient was also given 3 mg folic acid intramuscularly at the end of each dialysis period. The histidine supplementation consisted of 1 g histidine monohydrochloride a day for two months, given by mouth and split between two meals. The child received 300 mg histidine monohydrochloride a day, again divided into two doses.
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Results
The concentration of histidine in the serum, serum transferrin, plasma iron, reticulocyte count, and P.C.V. were all studied before and after the two months of histidine supplementation (table II) . The mean serum histidine concentration (± S.E.) rose from 0-792 ± 0-022 mg/100 ml to 1 491 ± 0 039 mg/100 ml after histidine supplementation (P <0 001; fig. 1 ). Transferrin also significantly increased from 198-1 ± 8-81 mg/100 ml to 268-3 10-17 mg/100 ml (P <0001; fig. 2 ). Plasma iron increased from 56-2 ± 2-27 F±g/100 ml to 85-0 ± 2-40 tLg/100 ml after histidine supplementation ( fig. 3 ). This difference was again statistically significant (P <0 001). The P.C.V. rose from 21-09 ± 1.09 to 25 75 ± 1-13 after histidine (P <0(001; fig. 4 ). Analysis of the reticulocyte count before and after two months 20- 
Discussion
Our earlier studies on the effects of histidine supplements in uraemia suggested that globin synthesis might be stimulated, but such a conclusion could not be fully justified on the basis of experiments in vitro (Giordano et al., b, 1970 (Giordano et al., , 1972 . The data obtained in the present study add further evidence, for they show that serum transferrin, plasma iron, and P.C.V. all rise after the plasma histidine level is raised by relatively small dietary supplements. Anaemia may ameliorate spontaneously during the course of regular dialysis (Eschbach et al. 1967) , particularly in the second and subsequent years, and this has been our experience with many patients. On the other hand we have been unable to relate P.C.V. to better control of uraemia (see table II ).
The increase in serum transferrin may be an effect of a better nutritional status rather than a consequence of increased iron. In fact, when iron levels rise transferrin levels do not directly follow the change of serum iron (Masson, 1971) . A strict correlation between the nutritional status of patients and levels of transferrin has, however, been established (Antia et al., 1968; McFarlane et al., 1969) . In addition to its nutritional effect the importance of histidine for synthesis of haemoglobin is multifactorial: it is needed for linking the haem group to the globin molecule which, in fact, contains a high proportion of histidine.
Recently, moreover, it has been suggested that histidine regulates gastrointestinal absorption of iron (Van Campen and Gross, 1970) , and this could explain the increase in plasma iron observed in our patients. It is not clear whether adding histidine to the diet enhances haemoblogin synthesis by a direct stimulatory effect on the reticulocytes or by its availability for incorporation into the haemoglobin molecule. The fact that reticulocyte counts were not increased after histidine supplementation may favour the second hypothesis.
Our results indicate that histidine has a beneficial effect on anaemia in uraemia. Since histidine is an innocuous and relatively inexpensive compound we suggest that it be used in an extensive controlled trial as a regular dietary supplement in dialysed patients. 
